Table 2. Clinical Profiles of 14 Patients without SWC.
| Patient number | Peak TSB (μmol/L) | Gender | Gestational age (d) | Onset Time(d) | Birth weight (g) | Diagnosis | MRI (yes/no) | Seizure (yes/no) | BAEP (grade) | EEG (grade) | Follow-up |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 996.2 | M | 40W | 4 | 2850 | G-6-PD deficiency | Ni | Y | 3 | 3 | CP |
| 2 | 737.0 | M | 35W+6 | 4 | 3100 | G-6-PD deficiency | Y | Y | 5 | 3 | MR, API |
| 3 | 650.4 | M | 37W+5 | 3 | 3200 | G-6-PD deficiency | Y | Y | 5 | 3 | LOST |
| 4 | 645.3 | F | 38W | 4 | 2980 | G-6-PD deficiency | Ni | Y | 5 | 3 | Following-up |
| 5 | 640.2 | M | 39W+2 | 1 | 2500 | G-6-PD deficiency | Y | Y | 5 | 3 | LOST |
| 6 | 616.9 | M | 40W+1 | 1 | 2800 | G-6-PD deficiency | Y | Y | 5 | 3 | MR, API |
| 7 | 600.0 | M | 40W+5 | 2 | 2700 | G-6-PD deficiency | N | Y | 3 | 3 | LOST |
| 8 | 591.2 | F | 38W+2 | 3 | 2790 | BI | Y | Y | 5 | 3 | MR, API |
| 9 | 483.9 | F | 37W+2 | 0 | 2700 | unknown | N | Y | 5 | 3 | API |
| 10 | 550.0 | M | 37W+1 | 3 | 3000 | G-6-PD deficiency | Ni | N | Ni | 4 | DEAD |
| 11 | 693.3 | M | 37W+2 | 3 | 3090 | G-6-PD deficiency | Ni | N | Ni | 4 | DEAD |
| 12 | 532.0 | F | 37W | 3 | 2700 | unknown | Y | Y | 5 | 4 | Following-up |
| 13 | 700.0 | F | 37W+5 | 1 | 2670 | unknown | N | Y | 5 | 4 | CP |
| 14 | 514.2 | M | 37W+2 | 0 | 2580 | unknown | Ni | N | 4 | 4 | LOST |
BI: Blood group incompatibility; MRI: Typical MRI in GP area (GP, globi pallidi); T2WI, T2-weighted images, Ni, Not implemented; EEG, Grade 1–4 represented normal, mild abnormal, moderate abnormal and severe abnormal EEG respectively; BAEP, brain-stem auditory evoked potential; Grade 1–5 represented normal, mild abnormal, moderate abnormal, severe abnormal and no response respectively; CP, cerebral palsy; MR: mental retardation; API, Auditory pathway injury;